regenerative
-
Regulatory
Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee™, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care
Introduction of RejuvaKnee™ expands Regenity’s innovation portfolio of sports medicine solutions, with anticipated market value of more than $900 million PARAMUS,…
Read More » -
Financial
Advanced Orthopedic Technologies, Implants and Regenerative Products Market Report, with Profiles of B. Braun Melsungen AG, Zimmer Biomet, Medtronic, Nuvasive and Stryker
DUBLIN, Dec. 22, 2023 /PRNewswire/ — The “Advanced Orthopedic Technologies, Implants and Regenerative Products” report has been added to ResearchAndMarkets.com’s offering. The global market for advanced…
Read More » -
Financial
U.S. Department of Defense Awards Theradaptive $4 Million Contract for Its OsteoAdapt Regenerative Therapeutic Program
FREDERICK, Md., March 1, 2023 /PRNewswire/ — Today, Theradaptive, a leading biotechnology company specializing in therapeutic delivery platforms, announces a Technology & Therapeutic Development…
Read More » -
Spine
HippoFi’s Regenerative Therapeutics Division Launches PURbridge™ for Spine Surgery
PURbridge™, an advanced synthetic and new form of bioactive glass, is positioned to significantly increase the Company’s revenue throughout 2023…
Read More » -
Financial
The Worldwide Orthopedic Regenerative Surgical Products Industry is Expected to Reach $5.6 Billion by 2030
DUBLIN, April 21, 2022 /PRNewswire/ — The “Orthopedic Regenerative Surgical Products Market Size, Share & Trends Analysis Report by Product (Allograft, Synthetic, Cell-based, Viscosupplements),…
Read More » -
Biologics
Integra LifeSciences Launches AmnioExcel® Plus Placental Allograft Membrane – The Next Generation in Amniotic Tissue Products
PRINCETON, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) — Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, today announced the…
Read More » -
Biologics
Graftless Bone Transplants Soon to Be Reality: ADAM Takes 3D Bones to Clinical Trials
GROTON, Conn., Dec. 3, 2019 /PRNewswire/ — On the shady campus of the BioCT accelerator in Groton, Connecticut, ADAM Project is preparing to take a…
Read More » -
Biologics
Regenerative Medicine Has a Bright Future
Written by Patrick Keeffe | February 10, 2017 U.S. Army scientists, working with medical technology companies, have successfully tested and used…
Read More » -
Biologics
With increasing incidence of bone and joint diseases and injuries, Regenerative Medicine Market is predicted to reach US $6.5B by 2019
JANUARY 14TH, 2017 – TRANSPARENCY MARKET RESEARCH The report presents a detailed summary of the historical development trajectory exhibited by…
Read More » -
Spine
Titan Spine pioneers regenerative medical device technology
by Ben Stanley In a conference room across the hall from a wall covered in framed patent licenses at the…
Read More » -
Recon
MiMedx to Webcast Its Analyst Day on October 13, 2015
MARIETTA, Ga., Sept. 15, 2015 /PRNewswire/ — MiMedx Group, Inc. MDXG, +1.45%the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
Biologics
Histogenics Corporation and Collagen Solutions plc Establish Supply Agreement
WALTHAM, Mass., Sept. 16, 2015 (GLOBE NEWSWIRE) — Histogenics Corporation (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing…
Read More » -
Biologics
MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference
MARIETTA, Ga., Aug. 3, 2015 /PRNewswire/ — MiMedx Group, Inc. MDXG, -4.85% the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes…
Read More » -
Hospitals
Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure
Tissue Regenix Group (AIM:TRX) (“Tissue Regenix” or “The Group”) the regenerative medical devices company, announces that it has further strengthened…
Read More »